For more cancer news, visit the Vanderbilt-Ingram Cancer Center website »
A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.
Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.
New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations.
The contractile machinery inside tumor cells increases invasive properties, suggesting it might be a good target to inhibit cancer cell spread.